From Ernst Greber, HAE Switzerland:

On Saturday, May 24, 2025, we will hold our annual patient meeting.

After a welcome coffee, various topics will be discussed.

• Various treatment options: Patients and HAE experts in conversation – valuable insights, information, and practical tips for everyday life.
• Healthy nutrition: The basis for a strong immune system and a better quality of life at any age.
• International HAE Association: Worldwide activities and goals.

After lunch, we will enjoy a tour of Zurich’s main train station or a walk around Zurich.

Following this, we will conclude the day with a final aperitif.

There is good news from the pharmaceutical industry, too: Swissmedic has granted CSL Behring approval for Andembry® (garadacimab) to prevent recurrent attacks of HAE.